Heparin Plays a Key Regulatory Role via a p53/FAK-Dependent Signaling in Melanoma Cell Adhesion and Migration

被引:20
作者
Chalkiadaki, Georgia [1 ]
Nikitovic, Dragana [1 ]
Berdiaki, Aikaterini [1 ]
Katonis, Pavlos [2 ]
Karamanos, Nikos K. [3 ]
Tzanakakis, George N. [1 ]
机构
[1] Univ Crete, Dept Histol, Sch Med, Iraklion 71003, Greece
[2] Univ Hosp Heraklion, Dept Orthoped, Iraklion 71003, Greece
[3] Univ Patras, Dept Chem, Biochem Lab, GR-26110 Patras, Greece
关键词
heparin; melanoma cell adhesion; migration; FAK; p53; IN-VITRO; KINASE; PROGRESSION; METASTASIS; EXPRESSION; BINDING; GROWTH; PROLIFERATION; FIBRONECTIN; ACTIVATION;
D O I
10.1002/iub.421
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heparin and its various derivatives affect cancer progression in humans. In this study, we show that heparin uptaken intracellularly by melanoma cells activated a signaling cascade, which in turn inhibited melanoma cell adhesion and migration. The reduced ability of M5 cells to adhere onto the fibronectin (FN) substrate was directly correlated to a decrease in the expression of focal adhesion kinase (FAK), which is a key regulator of melanoma motility. Cell treatment with heparin caused a marked downregulation in FAK expression (P <= 0.01). This is followed by an analogous inhibition of both constitutive and FN-induced FAK Y397-phosphorylation (P <= 0.01). Moreover, heparin stimulated the p53 expression (P <= 0.001) of M5 cells and its increased accumulation in the nucleus. This favors a decrease in FAK promoter activation and explains the reduced FAK transcript and protein levels. In conclusion, the results of this study clearly demonstrate that the action of heparin in the regulation of melanoma cell adhesion and migration involves a p53/FAK/signaling pathway, which may be of importance in molecular targeted therapy of the disease. (C) 2011 IUBMB IUBMB Life, 63(2): 109-119, 2011
引用
收藏
页码:109 / 119
页数:11
相关论文
共 38 条
[1]   FOCAL ADHESION KINASE (P125(FAK)) EXPRESSION CORRELATES WITH MOTILITY OF HUMAN-MELANOMA CELL-LINES [J].
AKASAKA, T ;
VANLEEUWEN, RL ;
YOSHINAGA, IG ;
MIHM, MC ;
BYERS, HR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (01) :104-108
[2]  
Barzu T, 1996, J CELL PHYSIOL, V167, P8, DOI 10.1002/(SICI)1097-4652(199604)167:1<8::AID-JCP2>3.0.CO
[3]  
2-T
[4]   Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest [J].
Bereczky, B ;
Gilly, R ;
Rásó, E ;
Vágó, A ;
Tímár, J ;
Tóvári, J .
CLINICAL & EXPERIMENTAL METASTASIS, 2005, 22 (01) :69-76
[5]   Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma [J].
Bogenrieder, T ;
Herlyn, M .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 44 (01) :1-15
[6]   BINDING AND INTERNALIZATION OF HEPARIN BY VASCULAR SMOOTH-MUSCLE CELLS [J].
CASTELLOT, JJ ;
WONG, K ;
HERMAN, B ;
HOOVER, RL ;
ALBERTINI, DF ;
WRIGHT, TC ;
CALEB, BL ;
KARNOVSKY, MJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 1985, 124 (01) :13-20
[7]   Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism [J].
Chalkiadaki, Georgia ;
Nikitovic, Dragana ;
Berdiaki, Aikaterini ;
Sifaki, Maria ;
Krasagakis, Kostantinos ;
Katonis, Pavlos ;
Karamanos, Nikos K. ;
Tzanakakis, George N. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (06) :1323-1331
[8]   Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling [J].
Chatzinikolaou, G. ;
Nikitovic, D. ;
Berdiaki, A. ;
Zafiropoulos, A. ;
Katonis, P. ;
Karamanos, N. K. ;
Tzanakakis, G. N. .
CELL PROLIFERATION, 2010, 43 (01) :9-18
[9]   Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements:: altered potential of hepatocellular carcinoma heparan sulphate [J].
Dudás, J ;
Ramadori, G ;
Knittel, T ;
Neubauer, K ;
Raddatz, D ;
Egedy, K ;
Kovalszky, I .
BIOCHEMICAL JOURNAL, 2000, 350 :245-251
[10]   Melanoma cell adhesion can be blocked by heparin in vitro: Suggestion of VLA-4 as a novel target for antimetastatic approaches [J].
Fritzsche, Juliane ;
Simonis, Dirk ;
Bendas, Gerd .
THROMBOSIS AND HAEMOSTASIS, 2008, 100 (06) :1166-1175